Overview

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This study will assess the effect of LCQ when added to metformin.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Metformin
Sitagliptin Phosphate